Citizens Financial Group Inc Ventyx Biosciences, Inc. Transaction History
Citizens Financial Group Inc
- $7.13 Billion
- Q3 2025
A detailed history of Citizens Financial Group Inc transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Citizens Financial Group Inc holds 142,193 shares of VTYX stock, worth $1.25 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
142,193Holding current value
$1.25 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VTYX
# of Institutions
118Shares Held
48.8MCall Options Held
70.4KPut Options Held
51.4K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.9MShares$51.7 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$41.8 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY4.54MShares$39.8 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.77MShares$33.1 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA3.1MShares$27.2 Million0.4% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $496M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...